Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiangkai Long"'
Publikováno v:
Functional & Integrative Genomics. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15912870ee0690a79a95f54c07a3ea15
https://doi.org/10.1007/s10142-023-00990-9
https://doi.org/10.1007/s10142-023-00990-9
Autor:
Zhike Song, Laijian Zheng, Xishun Luo, Xueyuan Gao, Xiangkai Long, Shiyu Jiang, Xinyang Xie, Haipeng Wang, Xijia Zhu
Publikováno v:
Oncol Lett
The efficacy of chemotherapy for colon cancer is limited due to the development of chemoresistance. MicroRNA (miR)-188-5p is downregulated in various types of cancer. The aim of the present study was to explore the molecular role of miR-188 in oxalip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5eee77b87547e1ffa38466dfbe4acff
https://europepmc.org/articles/PMC8100964/
https://europepmc.org/articles/PMC8100964/
Autor:
Xijia Zhu, Xishun Luo, Zhike Song, Shiyu Jiang, Xiangkai Long, Xuanyuan Gao, Xinyang Xie, Laijian Zheng, Haipeng Wang
Background: One main drawback of chemotherapy application in colon cancer clinically is drug resistance. miR-188-5p has been shown to be down-regulated in various types of cancer. The aim of this study was to explore the molecular mechanism of miR-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48564ef0010a6c10370943308263b927
https://doi.org/10.21203/rs.2.18041/v2
https://doi.org/10.21203/rs.2.18041/v2
Publikováno v:
Oncology Reports. 37:2245-2251
Colorectal adenocarcinoma is the third most common cancer worldwide. PARP6, a novel member of the poly(ADP-ribose) polymerases (PARPs) and survivin, a member of the family of inhibitor of apoptosis (IAP) proteins are associated with a poor prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3faf9d44fa305e326965472a186cb5b9
https://doi.org/10.3892/or.2017.5441
https://doi.org/10.3892/or.2017.5441
Publikováno v:
Oncology Reports; Apr2017, Vol. 37 Issue 4, p2245-2251, 7p
Autor:
Xijia Zhu, Xiangkai Long, Xishun Luo, Zhike Song, Shengguo Li, Haipeng Wang, Zhu, Xijia, Long, Xiangkai, Luo, Xishun, Song, Zhike, Li, Shengguo, Wang, Haipeng
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Sep2016, Vol. 31 Issue 7, p261-267, 7p